# Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1

> **NCT00265265** · PHASE1 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 16 (—)

## Conditions studied

- Cocaine-Related Disorders

## Interventions

- **DRUG:** Atomoxetine

## Key facts

- **NCT ID:** NCT00265265
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2006-09
- **Final completion:** —
- **Target enrollment:** 16 (—)
- **Last updated:** 2017-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00265265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00265265, "Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00265265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*